Merz offers Xeomin users financial assistance with new programs
GREENSBORO, N.C. — Merz Pharmaceuticals has created two programs to provide financial assistance to patients using its drug for cervical dystonia, the company said Tuesday.
The programs — the Xeomin patient co-payment program and the Xeomin patient assistance program — cover Xeomin (incobotulinumtoxinA), designed to decrease the severity of abnormal head positions and neck pains in patients with the disease, which causes muscle contractions resulting in repetitive movements and abnormal postures.
“By offering a continuum of Xeomin financial assistance programs, our hope is to help patients manage their cervical dystonia and blepharospasm costs by reducing or eliminating financial obstacles that may prevent initiation or continuation of treatment,” said Merz president and CEO Jack Britts.
APhA begins search for new CFO
WASHINGTON — The American Pharmacists Association is looking for a new CFO to replace Roger Browning, who will retire, the group said Tuesday.
Browning has worked in senior financial executive positions for the APhA since 1995, serving as SVP finance and CFO since 2007. Before working for the APhA, he was VP finance at the International Franchise Association.
“Roger Browning has done a phenomenal job of leading APhA through complex and challenging financial times the last 16 years as the organization grew exponentially and new subsidiary enterprises were created,” APhA EVP and CEO Tom Menighan said. “Additionally, Roger and his team guided us through the complexities of building and restoring a building on the National Mall.”
Walgreens’ Pegus to present during colloquium session
DEERFIELD, Ill. — Cheryl Pegus, chief medical officer at Walgreens, will make a presentation during the 11th annual Population Health and Care Coordination Colloquium in Philadelphia next week.
Pegus, who was named the drug store chain’s chief medical officer last May, will present during the “Impact and Value of Pharmacist Interventions in Different Settings” session, which will examine the growing role pharmacists are playing in improving clinical outcomes through interventions at community pharmacies and employer worksite health clinics, Walgreens said.
The news followed Walgreens’ announcement that it now is a member of Care Continuum Alliance, an alliance of more than 200 stakeholders providing services across the continuum of care — from wellness and prevention to chronic condition management and complex care management.
Back in January, Pegus spoke at the Consumer Electronics Show in Las Vegas and highlighted the increasing role of mobile technology in health care.
“Leveraging our unmatched national footprint and 70,000 affiliated healthcare providers to provide access to care and [helping to] address the challenge of chronic care management are two key areas of strategic focus for Walgreens,” Pegus said at CES earlier this year. “By using technology to improve the patient experience and coordination of care, we can continue to improve measurable outcomes, adherence and quality, while also providing cost-effective care.”